Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells

References 51

1. 1.

   Brooks L. A., Lear A. L., Young L. S., Rickinson A. B. Transcripts from the Epstein-Barr virus BamHI A fragment are detectable in all three forms of virus latency. J Virol. 1993;67(6):3182-3190.

   Not in our library10.1128/jvi.67.6.3182-3190.1993

2. 2.

   Brooks L., Yao Q. Y., Rickinson A. B., Young L. S. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts. J Virol. 1992;66(5):2689-2697.

   Not in our library10.1128/jvi.66.5.2689-2697.1992

3. 3.

   Busson P., McCoy R., Sadler R., Gilligan K., Tursz T., Raab-Traub N. Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma. J Virol. 1992;66(5):3257-3262.

   Not in our library10.1128/jvi.66.5.3257-3262.1992

4. 4.

   Chen F., Hu L. F., Ernberg I., Klein G., Winberg G. Coupled transcription of Epstein-Barr virus latent membrane protein (LMP)-1 and LMP-2B genes in nasopharyngeal carcinomas. J Gen Virol. 1995;76(Pt 1):131-138.

   Not in our library10.1099/0022-1317-76-1-131

5. 5.

   Cochet C., Martel-Renoir D., Grunewald V., Bosq J., Cochet G., Schwaab G., Bernaudin J. F., Joab I. Expression of the Epstein-Barr virus immediate early gene, BZLF1, in nasopharyngeal carcinoma tumor cells. Virology. 1993;197(1):358-365.

   Not in our library10.1006/viro.1993.1597

6. 6.

   Countryman J., Jenson H., Seibl R., Wolf H., Miller G. Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency. J Virol. 1987;61(12):3672-3679.

   Not in our library10.1128/jvi.61.12.3672-3679.1987

7. 7.

   Dawson C. W., Rickinson A. B., Young L. S. Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature. 1990;344(6268):777-780.

   Not in our library10.1038/344777a0

8. 8.

   Deacon E. M., Pallesen G., Niedobitek G., Crocker J., Brooks L., Rickinson A. B., Young L. S. Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells. J Exp Med. 1993;177(2):339-349.

   Not in our library10.1084/jem.177.2.339

9. 9.

   Dimery I. W., Lee J. S., Blick M., Pearson G., Spitzer G., Hong W. K. Association of the Epstein-Barr virus with lymphoepithelioma of the thymus. Cancer. 1988;61(12):2475-2480.

   Not in our library10.1002/1097-0142(19880615)61:12<2475::aid-cncr2820611215>3.0.co;2-5

10. 10.

    Fåhraeus R., Rymo L., Rhim J. S., Klein G. Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus. Nature. 1990;345(6274):447-449.

    Not in our library10.1038/345447a0

11. 11.

    Gilligan K., Sato H., Rajadurai P., Busson P., Young L., Rickinson A., Tursz T., Raab-Traub N. Novel transcription from the Epstein-Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma. J Virol. 1990;64(10):4948-4956.

    Not in our library10.1128/jvi.64.10.4948-4956.1990

12. 12.

    Greenspan J. S., Greenspan D., Lennette E. T., Abrams D. I., Conant M. A., Petersen V., Freese U. K. Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion. N Engl J Med. 1985;313(25):1564-1571.

    Not in our library10.1056/nejm198512193132502

13. 13.

    Harabuchi Y., Yamanaka N., Kataura A., Imai S., Kinoshita T., Mizuno F., Osato T. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet. 1990;335(8682):128-130.

    Not in our library10.1016/0140-6736(90)90002-m

14. 14.

    Herbst H., Dallenbach F., Hummel M., Niedobitek G., Pileri S., Müller-Lantzsch N., Stein H. Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc Natl Acad Sci U S A. 1991;88(11):4766-4770.

    Not in our library10.1073/pnas.88.11.4766

15. 15.

    Imai S., Koizumi S., Sugiura M., Tokunaga M., Uemura Y., Yamamoto N., Tanaka S., Sato E., Osato T. Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci U S A. 1994;91(19):9131-9135.

    Not in our library10.1073/pnas.91.19.9131

16. 16.

    Kerr B. M., Lear A. L., Rowe M., Croom-Carter D., Young L. S., Rookes S. M., Gallimore P. H., Rickinson A. B. Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: cell phenotype dependence of virus promoter usage. Virology. 1992;187(1):189-201.

    Not in our library10.1016/0042-6822(92)90307-b

17. 17.

    Khanna R., Burrows S. R., Kurilla M. G., Jacob C. A., Misko I. S., Sculley T. B., Kieff E., Moss D. J. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development. J Exp Med. 1992;176(1):169-176.

    Not in our library10.1084/jem.176.1.169

18. 18.

    Klein G., Lindahl T., Jondal M., Leibold W., Menézes J., Nilsson K., Sundström C. Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas. Proc Natl Acad Sci U S A. 1974;71(8):3283-3286.

    Not in our library10.1073/pnas.71.8.3283

19. 19.

    Korbjuhn P., Anagnostopoulos I., Hummel M., Tiemann M., Dallenbach F., Parwaresch M. R., Stein H. Frequent latent Epstein-Barr virus infection of neoplastic T cells and bystander B cells in human immunodeficiency virus-negative European peripheral pleomorphic T-cell lymphomas. Blood. 1993;82(1):217-223.

    Not in our library

20. 20.

    Lear A. L., Rowe M., Kurilla M. G., Lee S., Henderson S., Kieff E., Rickinson A. B. The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle. J Virol. 1992;66(12):7461-7468.

    Not in our library10.1128/jvi.66.12.7461-7468.1992

21. 21.

    Levitskaya J., Coram M., Levitsky V., Imreh S., Steigerwald-Mullen P. M., Klein G., Kurilla M. G., Masucci M. G. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature. 1995;375(6533):685-688.

    Not in our library10.1038/375685a0

22. 22.

    Leyvraz S., Henle W., Chahinian A. P., Perlmann C., Klein G., Gordon R. E., Rosenblum M., Holland J. F. Association of Epstein-Barr virus with thymic carcinoma. N Engl J Med. 1985;312(20):1296-1299.

    Not in our library10.1056/nejm198505163122006

23. 23.

    Li Q. X., Young L. S., Niedobitek G., Dawson C. W., Birkenbach M., Wang F., Rickinson A. B. Epstein-Barr virus infection and replication in a human epithelial cell system. Nature. 1992;356(6367):347-350.

    Not in our library10.1038/356347a0

24. 24.

    Miller C. L., Lee J. H., Kieff E., Longnecker R. An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking. Proc Natl Acad Sci U S A. 1994;91(2):772-776.

    Not in our library10.1073/pnas.91.2.772

25. 25.

    Miller C. L., Longnecker R., Kieff E. Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes. J Virol. 1993;67(6):3087-3094.

    Not in our library10.1128/jvi.67.6.3087-3094.1993

26. 26.

    Miller G., Lipman M. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc Natl Acad Sci U S A. 1973;70(1):190-194.

    Not in our library10.1073/pnas.70.1.190

27. 27.

    Miller W. E., Earp H. S., Raab-Traub N. The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor. J Virol. 1995;69(7):4390-4398.

    Not in our library10.1128/jvi.69.7.4390-4398.1995

28. 28.

    Moss D. J., Chan S. H., Burrows S. R., Chew T. S., Kane R. G., Staples J. A., Kunaratnam N. Epstein-Barr virus specific T-cell response in nasopharyngeal carcinoma patients. Int J Cancer. 1983;32(3):301-305.

    Not in our library10.1002/ijc.2910320307

29. 29.

    Murray R. J., Kurilla M. G., Brooks J. M., Thomas W. A., Rowe M., Kieff E., Rickinson A. B. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies. J Exp Med. 1992;176(1):157-168.

    Not in our library10.1084/jem.176.1.157

30. 30.

    Niedobitek G., Herbst H., Young L. S., Rowe M., Dienemann D., Germer C., Stein H. Epstein-Barr virus and carcinomas. Expression of the viral genome in an undifferentiated gastric carcinoma. Diagn Mol Pathol. 1992;1(2):103-108.

    Not in our library

31. 31.

    Nonkwelo C., Skinner J., Bell A., Rickinson A., Sample J. Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein. J Virol. 1996;70(1):623-627.

    Not in our library10.1128/jvi.70.1.623-627.1996

32. 32.

    Oda K., Tamaru J., Takenouchi T., Mikata A., Nunomura M., Saitoh N., Sarashina H., Nakajima N. Association of Epstein-Barr virus with gastric carcinoma with lymphoid stroma. Am J Pathol. 1993;143(4):1063-1071.

    Not in our library

33. 33.

    Pallesen G., Hamilton-Dutoit S. J., Rowe M., Young L. S. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet. 1991;337(8737):320-322.

    Not in our library10.1016/0140-6736(91)90943-j

34. 34.

    Patton D. F., Ribeiro R. C., Jenkins J. J., Sixbey J. W. Thymic carcinoma with a defective Epstein-Barr virus encoding the BZLF1 trans-activator. J Infect Dis. 1994;170(1):7-12.

    Not in our library10.1093/infdis/170.1.7

35. 35.

    Qu L., Rowe D. T. Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes. J Virol. 1992;66(6):3715-3724.

    Not in our library10.1128/jvi.66.6.3715-3724.1992

36. 36.

    Rogers R. P., Woisetschlaeger M., Speck S. H. Alternative splicing dictates translational start in Epstein-Barr virus transcripts. EMBO J. 1990;9(7):2273-2277.

    Not in our library10.1002/j.1460-2075.1990.tb07398.x

37. 37.

    Rooney C. M., Rickinson A. B., Moss D. J., Lenoir G. M., Epstein M. A. Cell-mediated immunosurveillance mechanisms and the pathogenesis of Burkitt's lymphoma. IARC Sci Publ. 1985;(60):249-264.

    Not in our library

38. 38.

    Rowe M., Rowe D. T., Gregory C. D., Young L. S., Farrell P. J., Rupani H., Rickinson A. B. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J. 1987;6(9):2743-2751.

    Not in our library10.1002/j.1460-2075.1987.tb02568.x

39. 39.

    Sample J., Brooks L., Sample C., Young L., Rowe M., Gregory C., Rickinson A., Kieff E. Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site. Proc Natl Acad Sci U S A. 1991;88(14):6343-6347.

    Not in our library10.1073/pnas.88.14.6343

40. 40.

    Schaefer B. C., Strominger J. L., Speck S. H. Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines. Proc Natl Acad Sci U S A. 1995;92(23):10565-10569.

    Not in our library10.1073/pnas.92.23.10565

41. 41.

    Schaefer B. C., Strominger J. L., Speck S. H. The Epstein-Barr virus BamHI F promoter is an early lytic promoter: lack of correlation with EBNA 1 gene transcription in group 1 Burkitt's lymphoma cell lines. J Virol. 1995;69(8):5039-5047.

    Not in our library10.1128/jvi.69.8.5039-5047.1995

42. 42.

    Schaefer B. C., Woisetschlaeger M., Strominger J. L., Speck S. H. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes. Proc Natl Acad Sci U S A. 1991;88(15):6550-6554.

    Not in our library10.1073/pnas.88.15.6550

43. 43.

    Shibata D., Tokunaga M., Uemura Y., Sato E., Tanaka S., Weiss L. M. Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Lymphoepithelioma-like carcinoma. Am J Pathol. 1991;139(3):469-474.

    Not in our library

44. 44.

    Shimizu N., Tanabe-Tochikura A., Kuroiwa Y., Takada K. Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV. J Virol. 1994;68(9):6069-6073.

    Not in our library10.1128/jvi.68.9.6069-6073.1994

45. 45.

    Sixbey J. W., Yao Q. Y. Immunoglobulin A-induced shift of Epstein-Barr virus tissue tropism. Science. 1992;255(5051):1578-1580.

    Not in our library10.1126/science.1312750

46. 46.

    Su I. J., Hsieh H. C., Lin K. H., Uen W. C., Kao C. L., Chen C. J., Cheng A. L., Kadin M. E., Chen J. Y. Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathologic and molecular analysis. Blood. 1991;77(4):799-808.

    Not in our library

47. 47.

    Takada K., Ono Y. Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. J Virol. 1989;63(1):445-449.

    Not in our library10.1128/jvi.63.1.445-449.1989

48. 48.

    Tierney R. J., Steven N., Young L. S., Rickinson A. B. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J Virol. 1994;68(11):7374-7385.

    Not in our library10.1128/jvi.68.11.7374-7385.1994

49. 49.

    Wang D., Liebowitz D., Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell. 1985;43(3 Pt 2):831-840.

    Not in our library10.1016/0092-8674(85)90256-9

50. 50.

    Young L. S., Lau R., Rowe M., Niedobitek G., Packham G., Shanahan F., Rowe D. T., Greenspan D., Greenspan J. S., Rickinson A. B. Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia. J Virol. 1991;65(6):2868-2874.

    Not in our library10.1128/jvi.65.6.2868-2874.1991

51. 51.

    Young L., Alfieri C., Hennessy K., Evans H., O'Hara C., Anderson K. C., Ritz J., Shapiro R. S., Rickinson A., Kieff E. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med. 1989;321(16):1080-1085.

    Not in our library10.1056/nejm198910193211604

Cited by papers we hold 2

• IFNγ induces PD-L1 overexpression by JAK2/STAT1/IRF-1 signaling in EBV-positive gastric carcinoma · 2017
  No notice
• Differences in Gastric Carcinoma Microenvironment Stratify According to EBV Infection Intensity: Implications for Possible Immune Adjuvant Therapy · 2013
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.